Rubinstein Linda M has filed 17 insider transactions across 1 company since February 2024.
Most recent transaction: a option exercise of 48750 shares of Adverum Biotechnologies, Inc. ($ADVM) on December 09, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | M | Stock Option (Right to Buy) | 48750 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.21% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | M | Common Stock | 48750 | $4.20 | 61,150.0000 | 23,487,000 | 393.15% | 0.21% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | U | Common Stock | 61150 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.26% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | U | Common Stock - Restricted Stock Units | 8125 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.03% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | A | Common Stock - Performance Stock Units | 42000 | $0.00 | 42,000.0000 | 23,487,000 | 9999.99% | 0.18% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | U | Common Stock - Performance Stock Units | 42000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.18% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | D | Stock Option (Right to Buy) | 35000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.15% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | D | Stock Option (Right to Buy) | 85000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.36% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | D | Stock Option (Right to Buy) | 62083 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.26% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 85000 | $0.00 | 85,000.0000 | 19,782,000 | 9999.99% | 0.43% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | D | Stock Option (Right to Buy) | 35000 | $0.00 | 0.0000 | 19,782,000 | 100.00% | 0.18% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 19,782,000 | 9999.99% | 0.18% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | D | Stock Option (Right to Buy) | 85000 | $0.00 | 0.0000 | 19,782,000 | 100.00% | 0.43% |
| Feb. 25, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 48750 | $0.00 | 48,750.0000 | 19,782,000 | 9999.99% | 0.25% |
| Feb. 25, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | A | Common Stock | 8125 | $0.00 | 19,325.0000 | 19,782,000 | 72.54% | 0.04% |
| Aug. 2, 2024 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 62083 | $0.00 | 62,083.0000 | 20,852,000 | 9999.99% | 0.30% |
| Feb. 12, 2024 | Adverum Biotechnologies, Inc. | $ADVM | Rubinstein Linda M | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 350000 | $0.00 | 350,000.0000 | 10,082,000 | 9999.99% | 3.47% |